Vacinas

Estudo randomizado | Vacina da Pfizer mostra 90,7% de eficácia na prevenção de Covid-19 em crianças de 5 a 11 anos de idade.

10 Nov, 2021 | 12:55h

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age – New England Journal of Medicine

 

Comentário no Twitter

In this multi-phase trial, two 10-μg doses of the BNT162b2 vaccine administered 21 days apart were safe, immunogenic, and 90.7% effective against #COVID19 in 5-to-11-year-old children. #Covid19vaccine https://t.co/kuj2eI4YCE pic.twitter.com/BWEkYxn8a0

— NEJM (@NEJM) November 9, 2021

 

---

Autoridade de saúde da França faz recomendações contra o uso da vacina da Moderna em menores de 30 anos de idade.

10 Nov, 2021 | 12:50h

French Health Authority Advises Against Moderna COVID-19 Vaccine for Under 30s – Reuters

Ver também: France advises against Moderna for under-30s over rare heart risk – Associated Press

Conteúdo relacionado: Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.

 

Comentário no Twitter

France's public health authority has recommended people under 30 be given Pfizer's Comirnaty COVID-19 vaccine when available instead of Moderna Inc's Spikevax jab, which carried comparatively higher risks of heart-related problems. https://t.co/4gPTXzEsw0

— Reuters Health (@Reuters_Health) November 9, 2021

 

---

Como as vacinas contra COVID baseadas em proteína podem mudar a pandemia.

9 Nov, 2021 | 12:19h

How protein-based COVID vaccines could change the pandemic – Nature

---

Sprays nasais, adesivos livres de agulhas, imunidade duradoura: a próxima geração de vacinas contra COVID.

9 Nov, 2021 | 12:18h

Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccines – The Conversation

 

---

[Ainda não publicado] Farmacêutica Sinovac afirma que sua vacina contra Covid-19 é segura para crianças e mesmo bebês a partir dos 6 meses de vida.

8 Nov, 2021 | 12:45h

Chinese drug firm Sinovac says Covid-19 vaccine safe for children, babies as young as six months old; submits data to Hong Kong government – South China Morning Post

Conteúdos relacionados:

Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.

Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

---

Ponto de vista | Vacinas contra COVID-19 na pediatria: o que pais, médicos e formadores de políticas públicas precisam saber.

8 Nov, 2021 | 12:43h

Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know – JAMA

---

Miocardite após vacina de mRNA contra COVID-19: uma série de casos e a determinação das taxas de incidência.

8 Nov, 2021 | 12:41h

Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination – Clinical Infectious Diseases

Conteúdos relacionados:

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

---

Vacinação contra COVID-19 em gestantes, crianças, pacientes imunocomprometidos, pessoas com histórico de alergia ou infecção prévia por SARS-CoV-2: visão geral das recomendações atuais e evidências pré e pós-marketing da eficácia e da segurança das vacinas.

8 Nov, 2021 | 12:40h

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety – Drug Safety

---

Alemanha oferece doses de reforço de vacina contra Covid-19 a todos em meio a um aumento de casos “muito preocupante”.

8 Nov, 2021 | 12:37h

Germany offers booster shots to everyone amid ‘very worrying’ surge in cases – CNN

---

Estudo compara a queda da efetividade das vacinas da Moderna, da Pfizer e da Janssen, além das consequências para a mortalidade.

5 Nov, 2021 | 17:21h

Estudo original: SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 – Science

Comunicado de imprensa: Breakthrough Infection Study Compares Decline in Vaccine Effectiveness and Consequences for Mortality – Public Health Institute

 

Comentário no Twitter

A new study of more than 780,000 United States Veterans shows that, although vaccination remains protective against #SARSCoV2 infection, protection waned as the Delta variant emerged in America.

Read more: https://t.co/8qRlKE107H #ScienceResearch pic.twitter.com/XmDQ7frIlT

— Science Magazine (@ScienceMagazine) November 4, 2021

 

---